|

Dulaglutide Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Also known as: LY2189265

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Eli Lilly and Company1
  • AdventHealth Translational Research Institute1

Indications

  • Diabetes2
  • Diabetes Mellitus, Type 11
  • Endothelial Dysfunction1
  • Type 2 Diabetes1

Tucson, Arizona1 trial

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

University of Arizona

Phase 3

Orlando, Florida1 trial

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

AdventHealth Translational Research Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.